RPG Life Sciences Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: RPG Life Sciences Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $12.3M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

RPG Life Sciences Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $12.3M Trade | TransData Nexus

RPG Life Sciences Limited

Indian Pharmaceutical Exporter · Immunosuppressants Specialist · $12.3M Total Trade · DGFT Verified

RPG Life Sciences Limited is an Indian pharmaceutical exporter with a total trade value of $12.3M across 2 products in 1 therapeutic categories. Based on 297 verified export shipments from Indian Customs (DGFT) records, RPG Life Sciences Limited is the #1 Indian exporter in 1 product including Azathioprine. Top exports include Azathioprine ($12.1M), Cyclosporine ($252.0K), .

RPG Life Sciences Limited — Export Portfolio & Destination Treemap

RPG Life Sciences Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is RPG Life Sciences Limited? — Company Overview & Market Position

RPG Life Sciences Limited, established in 1968, is an integrated pharmaceutical company headquartered in Mumbai, India. Initially known as Searle (India) Ltd, it underwent a name change to RPG Pharmaceuticals Limited in February 2008, and subsequently to RPG Life Sciences Limited. The company operates as a subsidiary of Nucleus Life Trust, a part of the RPG Enterprises conglomerate. RPG Enterprises, founded in 1979, is one of India's largest industrial conglomerates, with a turnover exceeding ₹23,000 crore.

RPG Life Sciences specializes in the development, manufacturing, and marketing of branded formulations, global generics, and synthetic active pharmaceutical ingredients (APIs). The company's diverse product portfolio spans 13 therapeutic areas, including nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, and more. As of the latest available data, RPG Life Sciences reported a revenue of ₹6.74 billion for the fiscal year ending March 2025. The company employs approximately 1,331 individuals.

What Does RPG Life Sciences Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Azathioprine$12.1M

Product Portfolio — Top 2 by Export Value

RPG Life Sciences Limited exports 2 pharmaceutical products across 1 therapeutic categories. Market leader (#1 exporter) in 1 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Azathioprine	Immunosuppressants	$12.1M	283	35.8%	1
2	Cyclosporine	Immunosuppressants	$252.0K	14	2.1%	8

RPG Life Sciences Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $12.3M. The company is the #1 Indian exporter in 1 product: Azathioprine. The top category is Immunosuppressants (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

RPG Life Sciences Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

RPG Life Sciences operates manufacturing facilities in Ankleshwar, Gujarat, and Navi Mumbai, Maharashtra. The Ankleshwar plant focuses on the production of finished dosage forms, while the Navi Mumbai facility specializes in the manufacturing of synthetic APIs. These facilities are equipped with state-of-the-art technology and adhere to stringent quality control measures to ensure the production of high-quality pharmaceutical products.

3Key Leadership

The leadership team at RPG Life Sciences is headed by Managing Director Ashok Nair, who has been instrumental in steering the company's strategic direction and growth. The Chief Financial Officer is Amol Narayan Lone, responsible for overseeing the company's financial operations. Other key executives include Rajesh Shirambekar, Head of Legal and Compliance Officer; Samir Rane, Vice President of Sales and Marketing; Sheetal Gaba, Chief Human Resources Officer; and Kartick C. Patra, Head of API Operations and Procurement.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does RPG Life Sciences Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

RPG Life Sciences has established a significant presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained regulatory approvals for its products in these regions, ensuring compliance with international standards. This regulatory compliance facilitates the export of its pharmaceutical formulations to these markets, expanding its global footprint. The company's commitment to quality and adherence to regulatory requirements have been pivotal in securing market access and maintaining a strong reputation among healthcare professionals and patients worldwide.

2Emerging Markets

RPG Life Sciences has strategically expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's products have been prequalified by the World Health Organization (WHO), enabling access to these regions and enhancing the availability of essential medicines. This prequalification underscores the company's dedication to providing affordable and high-quality therapies to underserved populations, thereby contributing to global health improvement.

3Geographic Strategy

RPG Life Sciences Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

RPG Life Sciences has registered its manufacturing facilities with the U.S. Food and Drug Administration (FDA), ensuring compliance with U.S. regulatory standards. The company has received approvals for its Abbreviated New Drug Applications (ANDAs), allowing it to market generic pharmaceutical products in the United States. Additionally, RPG Life Sciences has filed Drug Master Files (DMFs) with the FDA, providing detailed information about its manufacturing processes and quality control measures. The company's facilities have undergone FDA inspections, which have been completed satisfactorily, affirming the company's commitment to maintaining high-quality manufacturing practices.

2WHO & EU GMP

RPG Life Sciences has achieved prequalification from the World Health Organization (WHO) for several of its products, facilitating access to international markets and enhancing the availability of essential medicines. The company holds European Union Good Manufacturing Practice (EU GMP) certificates, demonstrating compliance with EU standards for pharmaceutical manufacturing. Additionally, RPG Life Sciences is listed in the European Directorate for the Quality of Medicines & HealthCare (EDQM) database, reflecting its adherence to European quality standards. These certifications underscore the company's commitment to delivering high-quality pharmaceutical products globally.

RPG Life Sciences Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

RPG Life Sciences operates in a competitive pharmaceutical market, with several key players in overlapping therapeutic categories. The company's flagship product, Azathioprine, holds a dominant market share, positioning RPG Life Sciences as a leader in the immunosuppressant segment. While specific market share data for other products is limited, the company's diversified portfolio across various therapeutic areas enables it to compete effectively in multiple segments. The company's focus on quality, regulatory compliance, and strategic partnerships enhances its competitive position in the global pharmaceutical industry.

2Key Differentiators

RPG Life Sciences' key differentiators include its strong presence in the immunosuppressant segment, particularly with its flagship product Azathioprine, which holds a 35.8% market share. The company's diverse product portfolio spans 13 therapeutic areas, allowing it to address a wide range of medical conditions. Additionally, RPG Life Sciences' commitment to quality is evident through its WHO prequalification and EU GMP certifications, ensuring adherence to international manufacturing standards. These factors collectively contribute to the company's competitive advantages in the pharmaceutical market.

3Strategic Position

Buyer Due Diligence Brief — Evaluating RPG Life Sciences Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

RPG Life Sciences has demonstrated a strong track record in pharmaceutical manufacturing, with a total export value of $12.3 million USD and 297 shipments across two products in the immunosuppressant category. The company's flagship product, Azathioprine, accounts for 35.8% of the market share, indicating consistent demand and reliability. The absence of regulatory actions such as Form 483 observations, warning letters, or import alerts further underscores the company's reliability and adherence to international standards. These factors collectively indicate that RPG Life Sciences is a dependable supplier in the pharmaceutical industry.

2Certifications to Verify

Importers should verify the following certifications when considering RPG Life Sciences as a supplier:

FDA Facility Registration: Confirm that the manufacturing facilities are registered with the U.S. Food and Drug Administration.

WHO Prequalification: Ensure that the company's products are prequalified by the World Health Organization.

Frequently Asked Questions — RPG Life Sciences Limited

How many pharmaceutical products does RPG Life Sciences Limited export from India?

RPG Life Sciences Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Azathioprine ($12.1M), Cyclosporine ($252.0K). Total export value is $12.3M.

What is RPG Life Sciences Limited's total pharmaceutical export value?

RPG Life Sciences Limited's total pharmaceutical export value is $12.3M, based on 297 verified shipments recorded in Indian Customs (DGFT) data.

In which products is RPG Life Sciences Limited the #1 Indian exporter?

RPG Life Sciences Limited is the #1 Indian exporter in 1 products: Azathioprine (35.8% market share).

What therapeutic categories does RPG Life Sciences Limited cover?

RPG Life Sciences Limited exports across 1 therapeutic categories. The largest are Immunosuppressants (100.0%, 2 products).

Get Full RPG Life Sciences Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.